换一批A phase I study of paclitaxel and epirubicin, without and with filgrastim, for the treatment of platinum-resistant advanced ovarian cancer.
第一作者：
R,Lauria
第一单位：
Dipartimento di Endocrinologia ed Oncologia Molecolare e Clinica, Facoltà di Medicina e Chirurgia, Università Federico II, Napoli, Italia.
作者：
医学主题词
成年人(Adult);老年人(Aged);抗生素类, 抗肿瘤(Antibiotics, Antineoplastic);抗肿瘤药, 植物(Antineoplastic Agents, Phytogenic);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);用药计划表(Drug Administration Schedule);抗药性, 肿瘤(Drug Resistance, Neoplasm);表柔比星(Epirubicin);女(雌)性(Female);非格司亭(Filgrastim);粒细胞集落刺激因子(Granulocyte Colony-Stimulating Factor);血液病(Hematologic Diseases);人类(Humans);白细胞计数(Leukocyte Count);中年人(Middle Aged);卵巢肿瘤(Ovarian Neoplasms);紫杉酚(Paclitaxel);铂化合物(Platinum Compounds);重组蛋白质类(Recombinant Proteins);治疗结果(Treatment Outcome)
DOI
10.1159/000011977
PMID
10343189
发布时间
2017-11-01
- 浏览0
Oncology
267-73页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
